Zhang, N., Zhang, Z., Yu, Y., Zhuo, Z., Zhang, G., & Zhang, B. (2020). Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy. Front Cell Dev Biol.

Zhang, Ning, Zong-Kang Zhang, Yuanyuan Yu, Zhenjian Zhuo, Ge Zhang, and Bao-Ting Zhang. "Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy." Front Cell Dev Biol 2020.

Zhang, Ning, et al. "Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy." Front Cell Dev Biol 2020.